National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Esophageal Cancer Trial Results
Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Browse by Cancer Type
Breast Cancer

Lung Cancer

Prostate Cancer

More Results
Search Trial Results

Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
Related Pages
Search for Clinical Trials
NCI's PDQ® registry of cancer clinical trials.

Esophageal Cancer Home Page
NCI's gateway for information about esophageal cancer.
1.  Radiation and Chemo Before Esophageal Cancer Surgery Improves Survival
(Posted: 08/21/2007) - Preoperative (neoadjuvant) use of combination chemoradiotherapy helped patients with localized esophageal cancer to live longer, according to the March 2007 Lancet Oncology.

2.  Patients With Esophageal Cancer May Be Able to Avoid Surgery
(Posted: 04/16/2007) - Patients with esophageal cancer lived just as long after receiving chemoradiation therapy alone as did those whose chemoradiation therapy was followed by surgery, according to the April 1, 2007, Journal of Clinical Oncology.

3.  New Chemotherapy Regimen Extends Survival for Patients with Resectable Gastric Cancer
(Posted: 07/12/2006) - When it comes to chemotherapy for locally invasive gastric cancer, results from an international clinical trial published in the July 6, 2006, issue of the New England Journal of Medicine suggest that timing can make all the difference.

4.  Frozen Glove Reduces Skin and Nail Damage from Docetaxel Chemotherapy
(Posted: 08/01/2005) - Patients who wore an experimental "frozen glove" to keep their hands very cold during intravenous chemotherapy with docetaxel (Taxotere®) had much less subsequent damage to the nails and skin of their hands, according to a study published in the July 1, 2005, issue of the Journal of Clinical Oncology.

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health